Log In
Sunday 21st January 2018

Cancer vaccine approved

29th September 2006

The European Union has approved Gardasil, the vaccine for cervical cancer. The UK Joint Committee on Vaccination and Immunisation will now advise the Department of Health whether it should be made available in the NHS.

Gardasil works against human papillomavirus types 6, 11, 16, and 18, which can lead to cervical cancer; it is designed to be given to girls and women aged 9 to 26 years.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018